Fundz
Free weekly newsletter

Get the free weekly executive digest

The new leadership moves, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New leadership moves, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Leadership Trends

See who's moving and how much in your market

No credit card required Weekly executive digest

Mark Walsh Appointed President and CEO of Triumph Pharmaceuticals

PRIVATESep 16, 2024•almost 2 years ago

Position

Chief Executive Officer

Company

Triumph Pharmaceuticals

Mark Walsh
St. LouisBiotechnologyHealth Care

Description

Mark Walsh has been appointed president and CEO of Triumph Pharmaceuticals, the company behind the SmartMouth oral care brand. His appointment is effective immediately. Walsh brings a wealth of consumer product experience, having started his career at P&G and then at Pepsi, where he gained international expertise in London and Dubai.

Company Information

Company

Triumph Pharmaceuticals

Location

St. Louis, Missouri, United States

About

SmartMouth Oral Health Laboratories (Triumph Pharmaceuticals Inc.), makers of the SmartMouth brand's line of products, was established in the mid-1990s, in St. Louis, Missouri. Its founder, Dr. Marvin Cohen, recognized a need for real solutions to a real problem: bad breath. As Chairman and Founder of Triumph Pharmaceuticals, Dr. Cohen was committed to the education and resolution of bad breath. With the distinction of being a leading authority on the etiology, diagnosis and treatment of halitosis, Dr. Cohen brought his years of extensive research and studies into the development of the SmartMouth products. He published 13 research projects and lectured extensively in the United States, Canada and Europe. Most notably, he is the author of the bad breath (halitosis) section of the Encyclopedia Britannica, 1998 Medical Edition.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Triumph Pharmaceuticals's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.